Search Details

Word: fda (lookup in dictionary) (lookup stats)
Dates: during 1990-1999
Sort By: most recent first (reverse)


Usage:

There is more bad news to come. Last month the FDA received a letter signed by several dozen neuroscientists blasting the agency for not opening up the post-approval monitoring process more fully. The FDA, these doctors charge, continues to ignore animal tests that suggest prolonged use of Redux can destroy nerve tissue. "Laboratories around the world have found that the drug has serious brain toxicity," says Dr. Mark Molliver of the Johns Hopkins Medical School. "It has the potential for producing brain damage...

Author: /time Magazine | Title: REDUX ON THE ROPES | 6/23/1997 | See Source »

...some respects Redux has been a victim of its own early success. The first new antiobesity medication in more than 20 years, the drug enjoyed one of the fastest launches in pharmaceutical history. Both the FDA and Wyeth-Ayerst Laboratories, which markets Redux, knew about the possibility of brain damage at high doses. But they also knew people who are morbidly obese--individuals who weigh 30% more than average--face even greater risks that they will die young from heart disease, diabetes or stroke. "We made the decision that the benefits outweigh the risks, at least for the population...

Author: /time Magazine | Title: REDUX ON THE ROPES | 6/23/1997 | See Source »

Still, the FDA was not entirely satisfied, and as a condition of approval it required that Wyeth-Ayerst conduct a follow-up study to determine whether Redux users were suffering any ill effects from the drug. Wyeth-Ayerst's critics say the company has been dragging its feet. Wyeth-Ayerst, for its part, says it is pleased with Redux's sales and is ready to start the tests, but that the FDA still has not decided how the study should be designed...

Author: /time Magazine | Title: REDUX ON THE ROPES | 6/23/1997 | See Source »

...meantime, the drug has become a magnet for bad press--most of it unwarranted, if not downright false. In February, after the FDA met behind closed doors with officials from Wyeth-Ayerst to iron out details of the follow-up study, critics cried "cover-up"--as if the FDA never granted drug companies private meetings in order to protect trade secrets. In April the Associated Press reported that a 38-year-old, 120-lb. woman had died after taking Redux for just a few days. It turned out that she weighed 220 lbs. and was in fact murdered--a turn...

Author: /time Magazine | Title: REDUX ON THE ROPES | 6/23/1997 | See Source »

WASHINGTON, D.C.: Joe Camel and the Marlboro Man will disappear from billboards, and by 2009, the FDA may ban nicotine altogether under a landmark, multibillion dollar settlement that will impose unprecedented regulations on America's tobacco industry. Under the agreement, tobacco companies will pay out $360 billion over 25 years into a settlement fund to finance public health campaigns and anti-smoking advertising, while disbursing $4 billion a year into a fund to pay damages in successful lawsuits brought by smokers. "We wanted to do something that would punish this industry for its past misconduct and we have done that...

Author: /time Magazine | Title: Tobacco Settlement Reached | 6/20/1997 | See Source »

Previous | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 53 | 54 | 55 | Next